Attributional Style and Adherence to Hydroxyurea in Adults with Sickle Cell Disease (HU Adherence Study)

verified Patient-friendly certified What is this?
The Sickle Cell 101 research team in collaboration with study investigator have reviewed this information to ensure it is patient-friendly and accurate.

About the Study

This study, conducted by Lance Archer, a doctoral student in the School of Psychology at Fielding Graduate University, Santa Barbara, CA, aims to understand why some adults with sickle cell disease (SCD) may have difficulties taking Hydroxyurea medication. Factors such as barriers to medication, mistrust in physicians and healthcare systems, communication between patients and providers, and beliefs about the medication can affect Hydroxyurea adherence.

Read more

Participation information

Countries

United States and Canada

Age

18 – 65 years

- 65

Gender

All

Genotypes

All types of SCD

Study Information

Study type

Survey

Phase

N/A

Compensation

Ten participants will be chosen at random to receive $50 Amazon Gift Card

Am I Eligible?

Requirements

You may be eligible to participate in this study if you:
  • Are an adult between the ages of 18 and 65
  • Have been diagnosed with sickle cell disease (SCD), including SS, SC, and S-β+ thalassemia
  • Reside in the United States or Canada
  • Have been taking Hydroxyurea for a minimum of 12 months
  • Have been under the care of a hematologist for a minimum of 12 months

Restrictions

You can't participate in this study if you:
  • Have been diagnosed with SCD non-related physical conditions, such as asthma, hypertension, diabetes, or other hemoglobinopathies
  • Have an intellectual disability
  • Have been diagnosed with severe psychiatric disorders, such as bipolar disorder, schizophrenia, or other thought disorders
  • Are younger than 18 years of age or older than 65.

Study point of contact

Lance Archer
N/A
[email protected]

Study Sites

  • United States
  • Canada
Enroll in this Study
Last updated November 30, 2024